Cameron brings a wealth of experience in the Bioanalytical field, with a particular focus on Toxicology. His extensive knowledge and global market expertise make him a valuable addition to Agilex's Leadership Team. As Chief Business Development Officer, Cameron will play a pivotal role in shaping Agilex's approach to the market.

Steve McIntyre, CEO of Agilex Biolabs, expressed his enthusiasm about this appointment, stating, "Given the exciting year ahead of us, I am very happy to welcome Cameron to this role and the Agilex Leadership Team. I believe his organizational abilities and industry insight will further enhance our company's position in the bioanalytical testing market."

Agilex Biolabs remains committed to providing high-quality services and advancing its position as a leader in the industry. The addition of Cameron Smith as Chief Business Development Officer is a testament to this commitment.